---
figid: PMC11852824__cells-14-00248-g010
figtitle: Combinational Inhibition of MEK and AKT Synergistically Induces Melanoma
  Stem Cell Apoptosis and Blocks NRAS Tumor Growth
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11852824
filename: cells-14-00248-g010.jpg
figlink: /pmc/articles/PMC11852824/figure/F10/
number: F10
caption: PI3K/AKT/Bcl2 and MAPK family pro-survival signaling pathway in CD133+ melanoma
  stem cells (MICs) and possible therapeutic targets
papertitle: Combinational Inhibition of MEK and AKT Synergistically Induces Melanoma
  Stem Cell Apoptosis and Blocks NRAS Tumor Growth
reftext: Ryyan Alobaidi, et al. Cells. 2025 Feb;14(4).
year: '2025'
doi: 10.3390/cells14040248
journal_title: Cells
journal_nlm_ta: Cells
publisher_name: Multidisciplinary Digital Publishing Institute  (MDPI)
keywords: NRAS | drug resistance | capivasertib | trametinib | xenograft | CRISPR-Cas9
automl_pathway: 0.9133833
figid_alias: PMC11852824__F10
figtype: Figure
redirect_from: /figures/PMC11852824__F10
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11852824__cells-14-00248-g010.html
  '@type': Dataset
  description: PI3K/AKT/Bcl2 and MAPK family pro-survival signaling pathway in CD133+
    melanoma stem cells (MICs) and possible therapeutic targets
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PROM1
  - AKT1
  - AKT2
  - AKT3
  - NRAS
  - RPS6KA1
  - RPS6KA2
  - RPS6KA3
  - RPS6KA4
  - RPS6KA5
  - RPS6KA6
  - RPS6KB1
  - RPS6KB2
  - BRAF
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - BAD
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - FOS
  - FOSB
  - FOSL1
  - FOSL2
  - BCL2
  - BAX
  - CASP1
  - CASP2
  - CASP4
  - CASP5
  - CASP6
  - CASP8
  - CASP9
  - CASP10
  - CASP12
  - CASP14
  - CASP3
  - CASP7
  - Trametinib
  - MEK
  - nucleus
  - Ser
---
